Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Repositorio y estudio cardíaco de la aplicación CHAMP (CHAMP)

13 de noviembre de 2026 actualizado por: Lori Erickson

Estudio cardíaco de la aplicación CHAMP: evaluación de funciones de software para la monitorización asincrónica de niños con cardiopatías congénitas complejas en el hogar y en el repositorio de datos

This is a multi-site research study with an optional research repository that will consist of clinically derived data and photographic or video images of patients in the home setting with complex health conditions to evaluate the safety and efficacy of the CHAMP® software platform, with data and photographic or video images input and/or uploaded by the parent or other legally authorized representative (LAR) of patients with complex congenital heart disease as a target population.

Descripción general del estudio

Estado

Inscripción por invitación

Intervención / Tratamiento

Descripción detallada

Study objectives

  1. To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated
  2. To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
  3. To evaluate the use of the CHAMP App for clinical purposes, including user satisfaction with the data entry, parental self-management, and transmission capabilities.
  4. To evaluate the real-world performance analytics (RWPA) of the CHAMP software platform for transfer of parent-entered data for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.

Endpoints

  1. To demonstrate that parents and caregivers for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated can accurately identify and transmit to healthcare providers specific health-related data including intake of food, fluids and mediations; output, including urination, defecation, and vomiting; weight; vital signs including oxygen saturation as measured by pulse oximetry; heart rate as measured either by a heart rate monitor or manually by the parent or caregiver; and temperature, measured by a reliable thermometer; and the value and reliability of videos provided by parents and caregivers regarding behavior of pediatric study participants for use in evaluating participant's health status.
  2. To demonstrate that data obtained through the use of devices such as pulse oximeters, as entered into the app by parents and caregivers, provide valuable information regarding the health status of children with Complex Diagnoses in a home setting.
  3. To demonstrate characteristics of CHAMP through real world health analytics (RWHA), user experience analytics (UX), and product performance analytics (PPA).

The study duration is open-ended for safety, effectiveness, and performance of the CHAMP app. Unless consent is withdrawn, data will be kept and used for data analysis and, if consented to the research repository for multi-site research purposes indefinitely. At age 18, previously pediatric patients may be approached for reconsent.

Tipo de estudio

De observación

Inscripción (Estimado)

1000

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • District of Columbia
      • Washington D.C., District of Columbia, Estados Unidos, 20010
        • Children's National Hospital
    • Florida
      • Miami, Florida, Estados Unidos, 33155
        • Nicklaus Variety Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Estados Unidos, 70118
        • Children's Hospital New Orleans
    • Missouri
      • Kansas City, Missouri, Estados Unidos, 64108
        • Children's Mercy Hospital
    • Ohio
      • Cincinnati, Ohio, Estados Unidos, 45219
        • Cincinnati Children's Hospital Medical Center
      • Columbus, Ohio, Estados Unidos, 43205
        • Nationwide Children's Hospital
    • Texas
      • Forth Worth, Texas, Estados Unidos, 76104
        • Cook's Children's
      • Houston, Texas, Estados Unidos, 77030
        • Children's Memorial Hermann Hospital
    • Utah
      • Salt Lake City, Utah, Estados Unidos, 84108
        • Primary Children's Hospital/University of Utah

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

No mayor que 18 años (Niño, Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Pediatric patients with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated in the home setting through a multi-regional approach.

Parents who utilize their CHAMP App and the healthcare team that log-in are also part of the CHAMP App study.

Descripción

Inclusion Criteria:

  • Age 0-17 years with a parent/Legally authorized representative
  • Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate.
  • Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring.
  • Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City.

Adult participants

  • Parents/Legally authorized representatives of pediatric subject.
  • Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.

Exclusion Criteria:

  • Inability to be discharged to care in the home setting.
  • Those not meeting the above inclusion criteria.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: OTHER

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Human factors/usability engineering: Login failures
Periodo de tiempo: Over a 3 month period

Rate of attempts of log-in failures

Over a 3 month period
Human factors/usability engineering: Imprecision
Periodo de tiempo: Over a 3 month period

Rate of data values reported with imprecision

Over a 3 month period
Clinical Safety: Anticipated adverse events
Periodo de tiempo: Over a 3 month period

Anticipated Adverse event rates

Over a 3 month period
Clinical Safety: Event resolution- anticipated
Periodo de tiempo: Time in days, reported over the last 3 months

Time to resolve anticipated adverse events

Time in days, reported over the last 3 months
Clinical Safety: Unanticipated Adverse events
Periodo de tiempo: Time in days, reported over the last 3 months

Unanticipated adverse event rates

Time in days, reported over the last 3 months
Clinical Safety: Event resolution- unanticipated
Periodo de tiempo: Time in days, reported over the last 3 months

Time to resolve unanticipated adverse events

Time in days, reported over the last 3 months
Health Benefits: Adherence
Periodo de tiempo: Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period

Rate of adherence to daily data entry

Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
User Satisfaction: Complaints
Periodo de tiempo: Over a 3 month period

Complaint rates via the healthcare team web portal

Over a 3 month period
User Satisfaction CHAMP Video
Periodo de tiempo: through study completion, an average of 9 months

Feedback from healthcare team will be received via treatment endpoint survey questions. Likert scale questions 1-strongly disagree to 5 strongly agree (Using CHAMP videos for the interstage monitoring of this patient improved clinical decisions for the home monitoring team). Available to put in comments.

through study completion, an average of 9 months
User Satisfaction: Communication
Periodo de tiempo: through study completion, an average of 9 months

Feedback from healthcare team will be received via treatment endpoint survey questions Likert scale questions 1-strongly disagree to 5 strongly agree ( Using CHAMP for the interstage monitoring of this patient improved communication with the parents at home.) Available to put in comments.

through study completion, an average of 9 months
User Engagement
Periodo de tiempo: Over a 3 month perriod

Total number of registered users (Active, treatment endpoint reached) and data totals per parent entered measure. De-identified Demographics and age areas utilization -Utilization across the number of pediatric sites, healthcare teams

Over a 3 month perriod
CHAMP app performance: Downtime
Periodo de tiempo: Over a 3 month period

Product Performance Analytics measured through Any system downtime

Over a 3 month period
CHAMP app performance: Cybersecurity
Periodo de tiempo: Over a 3 month period

Product Performance Analytics measured through Any reported breaches

Over a 3 month period
CHAMP app performance
Periodo de tiempo: Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required

Product Performance Analytics measured through --Bug/defect rate or Version failure rates

Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Lori Erickson, PhD, Director, Remote Health Solutions Children's Mercy

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

25 de agosto de 2023

Finalización primaria (Estimado)

31 de diciembre de 2027

Finalización del estudio (Estimado)

31 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

24 de agosto de 2023

Primero enviado que cumplió con los criterios de control de calidad

11 de septiembre de 2023

Publicado por primera vez (Actual)

13 de septiembre de 2023

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

Sí

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir